A

Assertio Holdings

D
ASRT
USD
0.01
(0.9901%)
Market Closed
9,335.00
Volume
-0.025
EPS
-
Div Yield
-0.210309
P/E
97,242,341.58
Market Cap
Today
0.9901%
1 Week
-0.488%
1 Month
-9.735%
6 Months
-7.692%
12 Months
-54.054%
Year To Date
-5.116%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
O
OPRX
0.163
(2.6699%)
USD
S
SNDX
0.16
(0.7491%)
USD
A
AMRN
-0.0379
(-6.1506%)
USD
V
VKTX
2.97
(4.5075%)
USD
K
KMPH
(%)
USD
G
GLPG
0.695
(2.5962%)
USD
A
ALLK
-0.06
(-4.2553%)
USD
A
ACST
(%)
USD
O
OPTN
0.0893
(12.7517%)
USD

Title:
Assertio Holdings

Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.
Do you need help or have a question?
Contact Us